Agilent Technologies is developing a series of ultra-high-field nuclear magnetic resonance (NMR) spectrometers at 850MHz and 1GHz.
As part of its strategy to expand NMR applications, Agilent has also entered into a co-marketing agreement with Bridge12 Technologies.
Bridge12 is a provider of terahertz technology, a critical component for an emerging application known as dynamic nuclear polarisation (DNP).
DNP can significantly improve measurement sensitivity for solid-state samples.
The co-marketing agreement enables the commercialisation of DNP NMR systems, including Bridge12's terahertz gyrotron and transmission line system.
According to Bridge12, its gyrotrons for DNP-NMR systems are turnkey, low-maintenance and designed specifically for the requirements of the NMR community.
These projects are significant milestones toward establishing Agilent as a technology leader in nuclear magnetic resonance.
In addition to its expanded Centre of Excellence in Santa Clara, California, the company is building an ultra-high-field demonstration facility at its Magnet Technology Centre in Yarnton, England.
The Santa Clara centre is currently open, while the facility in Yarnton will open in September.
Both are designed to give customers hands-on experience with the newest NMR systems throughout the development process.
